Related Experiment Video

Updated: Jun 26, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Cancer vaccines: current directions and perspectives in prostate cancer

Mahsa Mohebtash1, James L Gulley, Ravi A Madan

  • 1Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Current Opinion in Molecular Therapeutics
|January 27, 2009
PubMed

Insights

Cancer vaccines show promise for treating various tumors, especially prostate cancer. Advances in antigen identification and delivery systems enhance efficacy, with new combination strategies offering novel therapeutic perspectives.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Cancer vaccines are an evolving therapeutic strategy for various malignancies.
  • Improvements in tumor antigen characterization, vaccine delivery, and immunostimulant combinations have enhanced vaccine efficacy.
  • Prostate cancer presents unique characteristics, making it a promising candidate for immunotherapy.

Purpose of the Study:

  • To review advancements in cancer vaccine development and efficacy.
  • To highlight prostate cancer as an ideal target for immunotherapy.
  • To discuss novel strategies combining cancer vaccines with other therapies for prostate cancer treatment.

Main Methods:

  • Review of current research on cancer vaccines.
  • Analysis of tumor-associated antigens and vaccine delivery systems.
  • Exploration of combination therapies involving vaccines and immunostimulants.

Main Results:

  • Cancer vaccine efficacy has improved due to better antigen discovery and delivery systems.
  • Prostate cancer's slow progression and specific antigens support its suitability for immunotherapy.
  • Combination strategies are emerging as promising approaches for enhanced treatment outcomes.

Conclusions:

  • Cancer vaccines represent a significant therapeutic modality with increasing efficacy.
  • Prostate cancer is a strong candidate for immunotherapy due to its biological characteristics.
  • Future directions involve combining vaccines with other treatments for improved prostate cancer management.

More Related Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.